← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Quralis Corporation
Cambridge, MA
$1,081,695
Total funding
4
Grants
Funding over time
peak $857.6K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,081,695 · 3
DOD$0 · 1
By mechanism
R44$857,576 · 2
R43$224,119 · 1
—$0 · 1
Investigators at Quralis Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Preclinical development of a Stathmin-2 splicing modulator for ALS$499,987
R44 · FY2020 · NS
Development of a therapeutic Kv7 opener to restore motor excitability in ALS$357,589
R44 · FY2020 · NS
Development of a human cellular TBK1 model for drug discovery in ALS$224,119
R43 · FY2019 · NS
VALIDATION OF A STMN2-BASED BIOMARKER FOR ALS PATIENT IDENTIFICATION AND TARGET ENGAGEMENT IN CLINICAL STUDIES$0
· FY2022 · Defense Health Agency